Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Neurotune chief executive Bruno Oesch

Working Life: Neurotune’s chief executive

June 22, 2011 Business Services, Research and Development Working Life, recruitment

Bruno Oesch, chief executive of Swiss biopharmaceutical company Neurotune, talks to Pharmafocus about being at the interface of science and …
News
rocheroof

Mid-stage trial boost for Roche skin cancer drug vismodegib

June 20, 2011 Research and Development Cancer, Roche, skin cancer, vismodegib

Roche’s novel skin cancer drug vismodegib has met its primary endpoint in a phase II trial. Vismodegib is an investigational, …
News

Actelion plans biotech start-up

June 20, 2011 Research and Development Actelion, biotech

Swiss biopharmaceutical company Actelion is planning to launch a biotech start-up that would run separately from the main company. It …
News

Stem cell trial aims to cure macular degeneration

June 17, 2011 Research and Development AMD, Advanced Cell Technology, Stargardt’s Macular Dystrophy, Stem cells, stem cell

A groundbreaking trial to explore the use of stem cells to treat macular degeneration has been launched. US company Advanced …
News
AstraZeneca

AZ establishes predictive science centre in Russia

June 17, 2011 Research and Development AstraZeneca, Russia, predictive science

AstraZeneca is moving further into Russia with the establishment in St. Petersburg of a facility which aims to better assess …
News

Biocair appoints new business development managers

June 16, 2011 Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development

Biocair has appointed two new business development managers, Natalie Gerrard and Steve Taylor. Natalie Gerrard was promoted internally from within …
Appointment
Sanofi headquarters

Sanofi signs regenerative medicines collaboration

June 16, 2011 Research and Development Audion, Sanofi, hearing loss

Sanofi has signed a research pact with Audion Therapeutics to develop regenerative medicines for hearing loss. The company’s two-year deal …
News

GSK takes control of China vaccines venture

June 15, 2011 Manufacturing and Production, Research and Development, Sales and Marketing China, GSK, Shenzhen Neptunus Interlong Bio-Technique Co, vaccines

GlaxoSmithKline is increasing its footprint in China, shelling out £24 million ($39 million) to buy the remaining stake in a …
News

Arecor and GSK collaborate on vaccine technology

June 15, 2011 Manufacturing and Production, Research and Development Arecor, GSK, vaccines

GSK is to team up with UK company Arecor to develop advanced formulations of GSK’s vaccines. Cambridge-based Arecor has developed …
News
ABPI social media internet guidelines

Digital Pharma: Pharmacovigilance, the internet and social media

June 15, 2011 Medical Communications, Research and Development, Sales and Marketing Digital Pharma blog, adverse event reporting, adverse events, pharmacovigilance

This week the ABPI released guidance on managing adverse events from social media and the internet in a document that …
Feature
Cephalon

Teva’s Cephalon acquisition could be delayed

June 15, 2011 Manufacturing and Production, Research and Development, Sales and Marketing Cephalon, Teva

The Federal Trade Commission has requested more information about Teva’s deal with Cephalon, potentially delaying the purchase by a month. …
News
Merck & Co

Merck to develop biosimilar of Pfizer’s Enbrel

June 15, 2011 Research and Development, Sales and Marketing Enbrel, Merck & Co, biosimilar

Merck & Co is to develop its own version of Pfizer’s ageing arthritis drug Enbrel with a South Korean manufacturer. …
News

Xceleron appoints Dr Stuart Best

June 14, 2011 Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development

Dr Stuart Best has joined Xceleron as senior director operations, moving to the company from Merck in Scotland where he …
Appointment
Pfizer's Sandwich, Kent research site

Pfizer’s Sandwich site on market as ‘discovery park’

June 14, 2011 Research and Development Pfizer, Sandwich, UK pharma

Pfizer has expanded its options for its main European research site, earmarked for closure in Feburary, and is now marketing …
News

Innovation – is it science or art?

June 14, 2011 Manufacturing and Production, Research and Development creativity, drug development, innovation

In recent times new drug development has shown a substantial decline in the number of approved drugs for human use. …
Feature
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026